Table 3.
n (Total 392) | % Total (95% CI) | |
---|---|---|
HPV Negative by RNAseq | 223 | 56.89 (51.82–61.85) |
HPV Positive by RNAseq | 169 | 43.11 (38.15–48.18) |
HPV 16 | 4 | 1.02 (0.28–2.59) |
HPV 18 | 1 | 0.26 (0.01–1.41) |
HPV 31 | 19 | 4.85 (2.94–7.47) |
HPV 32 | 1 | 0.26 (0.01–1.41) |
HPV 33 | 58 | 14.80 (11.43–18.70) |
HPV 34 | 3 | 0.77 (0.16–2.22) |
HPV 35 | 3 | 0.77 (0.16–2.22) |
HPV 38 | 1 | 0.26 (0.01–1.41) |
HPV 39 | 8 | 2.04 (0.89–3.98) |
HPV 42 | 2 | 0.51 (0.06–1.83) |
HPV 45 | 17 | 4.34 (2.55–6.85) |
HPV 52 | 2 | 0.51 (0.06–1.83) |
HPV 53 | 2 | 0.51 (0.06–1.83) |
HPV 54 | 1 | 0.26 (0.01–1.41) |
HPV 56 | 8 | 2.04 (0.89–3.98) |
HPV 58 | 8 | 2.04 (0.89–3.98) |
HPV 59 | 4 | 1.02 (0.28–2.59) |
HPV 66 | 1 | 0.26 (0.01–1.41) |
HPV 68 | 1 | 0.26 (0.01–1.41) |
HPV 70 | 1 | 0.26 (0.01–1.41) |
HPV 73 | 23 | 5.87 (3.76–8.67) |
HPV 82 | 1 | 0.26 (0.01–1.41) |
Number of HPV PCR negative specimens that turn HPV positive after being subjected to RNAseq. Highlighted with bold HPV genotypes are the types which present specific probes for the PCR-based detection method.